Table 1.
Baseline Descriptive Statistics by Group
| Demographic | Control | Treatment | ||||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| n | % Total | M | SD | n | % Total | M | SD | |
|
| ||||||||
| Age | 18 | 100 | 31.4 | 8.64 | 18 | 100 | 40.10 | 13.80 |
| Gender (Female) | 12 | 67 | - | - | 13 | 72 | - | - |
| Y-BOCS Total | 18 | 100 | 25.30 | 4.31 | 18 | 100 | 26.80 | 4.92 |
| Education (years) | 18 | 100 | 14.72 | 2.27 | 18 | 100 | 14.28 | 2.30 |
| Psychiatric Comorbidity MDD PTSDs Anxiety disorder OCRD Eating disorder |
8 4 2 4 1 1 |
44 22 11 22 6 6 |
- - - - - - |
- - - - - - |
8 6 2 3 0 1 |
44 33 11 17 0 6 |
- - - - - - |
- - - - - - |
| Psychoactive medication SSRI Clomipramine As-needed sleep medication Thyroid hormone Cabergoline |
7 6 1 0 1 1 |
39 33 6 0 6 6 |
- - - - - - |
- - - - - - |
5 3 0 1 1 0 |
28 17 0 6 6 0 |
- - - - - - |
- - - - - - |
Note: N = 36 participants randomized. MDD – Major Depressive Disorder; PTSD – Post-traumatic stress disorder; OCRD – obsessive-compulsive related disorder; SSRI – selective serotonin reuptake inhibitor